A phase 2 basket study of talabostat, a small‐molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers

Documenti analoghi

• A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
  di: Omar Alhalabi, et al.
  Pubblicazione: (2025)
• Rapid screening and identification of novel dipeptidyl peptidase IV inhibitory peptides from buffalo milk
  di: Qianqian Zheng, et al.
  Pubblicazione: (2025)
• Design and experimental verification of novel angiotensin‐converting enzyme and dipeptidyl peptidase IV inhibitory peptides from Ziziphus jujuba peptide KALVAP
  di: Huan Wen, et al.
  Pubblicazione: (2025)
• Comparison of renal prognosis between dipeptidyl peptidase‐4 inhibitor users and non‐users
  di: Hideaki Hashimoto, et al.
  Pubblicazione: (2024)
• Selective targeting of dipeptidyl‐peptidase 4 (DPP‐4) positive senescent chondrocyte ameliorates osteoarthritis progression
  di: Du Hyun Ro, et al.
  Pubblicazione: (2024)